Literature DB >> 448142

Increased prostaglandin production by human monocytes after membrane receptor activation.

J H Passwell, J M Dayer, E Merler.   

Abstract

Human monocytes in culture release small amounts of prostaglandin E (PGE) into the medium. Addition of Fc fragments of IgG to human monocyte monolayer cultures results in a marked increase in PGE release; Fab fragments, monomeric IgG, and human serum albumin have no effect. An IgG1 myeloma has no effect on PGE levels but addition of the heat aggreagted protein results in a marked increase of PGE secretion. Exposure of the cells to Con A, which binds to a specific monocyte plasma membrane receptor, also results in a large increase in PGE release. The magnitude of the increase in PGE secretion produced by exposure of the monocytes to these ligands greatly exceeds the stimulation observed after the addition of antigen-activated mononuclear cell supernatants, zymosan, Sephadex beads, or endotoxin, to monocyte cultures. Prostaglandin E2 (PGE2) accounts for approximately 70% of the total prostaglandins released by stimulated cells. After addition of Indomethacin to monocyte cultures, the stimulatory effects of the ligands on PGE release are inhibited. Addition of Con A to monocyte cultures results in an increased incorporation of [3H]-arachidonic acid into PGE2. These results suggest that this ligand stimulates synthesis as well as release of this prostaglandin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Activation of human monocytes via their sIgA receptors.

Authors:  S Padeh; C L Jaffe; J H Passwell
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

2.  Effect of aggregated IgG on mononuclear and polymorphonuclear cell cooperation.

Authors:  T Appelboom; G Amerijckx; N Mairesse; M Pierart
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

3.  Genetic control of oral tolerance to ovalbumin in mice.

Authors:  A G Lamont; A M Mowat; M J Browning; D M Parrott
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

Review 4.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

5.  The effect of human monocytes and macrophages on lymphocyte proliferation.

Authors:  J H Passwell; M Levanon; J Davidsohn; F Kohen; B Ramot
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

6.  Perifused alveolar macrophages. A technique to study the effects of toxicants on prostaglandin release.

Authors:  P Sirois; A Cadieux; M Rola-Pleszcynski; R Bégin
Journal:  Experientia       Date:  1982-09-15

7.  Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.

Authors:  M E Kleinhenz; J J Ellner; P J Spagnuolo; T M Daniel
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

8.  Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy.

Authors:  A Durandy; A Fischer; C Griscelli
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

Review 9.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

10.  Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures.

Authors:  N A Pawlowski; G Kaplan; A L Hamill; Z A Cohn; W A Scott
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.